Last reviewed · How we verify

NCT06257316

Appropriate Dosage of Vasopressor in Neonates and Infants

Not yet recruiting Phase 4 Last updated 15 February 2024
What this trial tests

Phase 4 trial testing EPHEDrine Hydrochloride 5 mg/ml in Hypotension in 132 participants. Not yet recruiting.

Timeline
15 February 2024
Primary endpoint
28 February 2027
28 February 2028

Quick facts

Lead sponsorSeoul National University Hospital
PhasePhase 4
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingquadruple
Primary purposetreatment
Enrollment132
Start date15 February 2024
Primary completion28 February 2027
Estimated completion28 February 2028

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Under 2, any sex, with Hypotension or Neonatal Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators will evaluate cerebral blood flow before and after drug infusion using ultrasound to suggest blood pressure criteria and dosage of ephedrine, a vasopressor, to maintain adequate cerebral blood flow in neonates and infants undergoing surgery and anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypotension

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06257316.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing